Equities research analysts at Lifesci Capital issued their FY2024 earnings per share (EPS) estimates for shares of Immunome in a note issued to investors on Tuesday, March 11th. Lifesci Capital ...
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) has been given an average rating of “Buy” by the seven brokerages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback